Mostrar el registro sencillo del ítem
Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease
dc.contributor.author | Requejo C. | |
dc.contributor.author | Ruiz-Ortega J.A. | |
dc.contributor.author | Cepeda H. | |
dc.contributor.author | Sharma A. | |
dc.contributor.author | Sharma H.S. | |
dc.contributor.author | Ozkizilcik A. | |
dc.contributor.author | Tian R. | |
dc.contributor.author | Moessler H. | |
dc.contributor.author | Ugedo L. | |
dc.contributor.author | Lafuente J.V. | |
dc.date.accessioned | 2020-09-02T22:26:54Z | |
dc.date.available | 2020-09-02T22:26:54Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1007/s12035-017-0741-x | |
dc.identifier.citation | 55, 1, 286-299 | |
dc.identifier.issn | 08937648 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5975 | |
dc.description | Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson’s disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6- hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine- induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/ Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotectiveneurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD. © Springer Science+Business Media, LLC 2017. | |
dc.language.iso | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | 6-OHDA | |
dc.subject | Enriched environment | |
dc.subject | Nanowired cerebrolysin | |
dc.subject | Neuroprotection | |
dc.subject | Parkinson’s disease | |
dc.subject | Preclinical stage | |
dc.subject | caspase 3 | |
dc.subject | cerebrolysin | |
dc.subject | mitogen activated protein kinase | |
dc.subject | mitogen activated protein kinase 1 | |
dc.subject | mitogen activated protein kinase 3 | |
dc.subject | nanowire | |
dc.subject | protein kinase B | |
dc.subject | tyrosine 3 monooxygenase | |
dc.subject | amino acid | |
dc.subject | cerebrolysin | |
dc.subject | nanoparticle | |
dc.subject | neuroprotective agent | |
dc.subject | Akt signaling | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | caudate nucleus | |
dc.subject | controlled study | |
dc.subject | corpus striatum | |
dc.subject | drug effect | |
dc.subject | environmental enrichment | |
dc.subject | male | |
dc.subject | MAPK signaling | |
dc.subject | motor dysfunction | |
dc.subject | nerve cell network | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | Parkinson disease | |
dc.subject | protein expression | |
dc.subject | putamen | |
dc.subject | rat | |
dc.subject | rearing | |
dc.subject | substantia nigra | |
dc.subject | therapy effect | |
dc.subject | animal | |
dc.subject | disease model | |
dc.subject | drug delivery system | |
dc.subject | environment | |
dc.subject | metabolism | |
dc.subject | parkinsonism | |
dc.subject | pathology | |
dc.subject | procedures | |
dc.subject | Sprague Dawley rat | |
dc.subject | Amino Acids | |
dc.subject | Animals | |
dc.subject | Disease Models, Animal | |
dc.subject | Drug Delivery Systems | |
dc.subject | Environment | |
dc.subject | Male | |
dc.subject | Nanoparticles | |
dc.subject | Neuroprotective Agents | |
dc.subject | Parkinsonian Disorders | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.title | Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease | |
dc.type | Article |